메뉴 건너뛰기




Volumn 26, Issue 12, 1999, Pages 2539-2543

Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis

Author keywords

Celecoxib; Methotrexate; Pharmacokinetics; Renal clearance; Rheumatoid arthritis; Specific cyclooxygenase 2 inhibitors; Toxicity

Indexed keywords

CELECOXIB; METHOTREXATE;

EID: 0032755693     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (58)

References (34)
  • 1
    • 0031949858 scopus 로고    scopus 로고
    • Combination therapy in rheumatoid arthritis: Updated systematic review
    • Verhoeven AC, Boers M, Tugwell P. Combination therapy in rheumatoid arthritis: Updated systematic review. Br J Rheumatol 1998;37:612-9.
    • (1998) Br J Rheumatol , vol.37 , pp. 612-619
    • Verhoeven, A.C.1    Boers, M.2    Tugwell, P.3
  • 3
    • 0028874225 scopus 로고
    • Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: Association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy
    • Kremer JM, Petrillo GF, Hamilton RA. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: Association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy. J Rheumatol 1995;22:38-40.
    • (1995) J Rheumatol , vol.22 , pp. 38-40
    • Kremer, J.M.1    Petrillo, G.F.2    Hamilton, R.A.3
  • 4
    • 0027171787 scopus 로고
    • Renal effects of low-dose methotrexate in rheumatoid arthritis
    • Seideman P, Müller-Suur R, Ekman E. Renal effects of low-dose methotrexate in rheumatoid arthritis. J Rheumatol 1993;20:1126-8.
    • (1993) J Rheumatol , vol.20 , pp. 1126-1128
    • Seideman, P.1    Müller-Suur, R.2    Ekman, E.3
  • 5
    • 0027478126 scopus 로고
    • Renal toxicity of the nonsteroidal antiinflammatory drugs
    • Murray MD, Brater DC. Renal toxicity of the nonsteroidal antiinflammatory drugs. Annu Rev Pharmacol Toxicol 1993; 33:435-65.
    • (1993) Annu Rev Pharmacol Toxicol , vol.33 , pp. 435-465
    • Murray, M.D.1    Brater, D.C.2
  • 7
    • 0025989927 scopus 로고
    • Low dose MTX and NSAID induced mild renal insufficiency and severe neutropenia
    • Kraus A, Alarcon-Segovia D. Low dose MTX and NSAID induced mild renal insufficiency and severe neutropenia [letter]. J Rheumatol 1991;18:1274.
    • (1991) J Rheumatol , vol.18 , pp. 1274
    • Kraus, A.1    Alarcon-Segovia, D.2
  • 8
    • 0027364975 scopus 로고
    • Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate
    • Rooney TW, Furst DE, Koehnke R, Burmeister L. Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate. J Rheumatol 1993;20:1297-302.
    • (1993) J Rheumatol , vol.20 , pp. 1297-1302
    • Rooney, T.W.1    Furst, D.E.2    Koehnke, R.3    Burmeister, L.4
  • 9
    • 0029924144 scopus 로고    scopus 로고
    • Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate
    • Franck H, Rau R, Herborn G. Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate. Clin Rheumatol 1996;15:429-30.
    • (1996) Clin Rheumatol , vol.15 , pp. 429-430
    • Franck, H.1    Rau, R.2    Herborn, G.3
  • 10
    • 0026502732 scopus 로고
    • The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis
    • Tracy TS, Krohn K, Jones DR, Bradley JD, Hall SD, Brater DC. The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis. Eur J Clin Pharmacol 1992;42:121-5.
    • (1992) Eur J Clin Pharmacol , vol.42 , pp. 121-125
    • Tracy, T.S.1    Krohn, K.2    Jones, D.R.3    Bradley, J.D.4    Hall, S.D.5    Brater, D.C.6
  • 11
    • 0026570125 scopus 로고
    • Methotrexate and nonsteroidal antiinflammatory drug interactions
    • Frenia ML, Long KS. Methotrexate and nonsteroidal antiinflammatory drug interactions. Ann Pharmacother 1992;26:234-7.
    • (1992) Ann Pharmacother , vol.26 , pp. 234-237
    • Frenia, M.L.1    Long, K.S.2
  • 12
    • 0025678922 scopus 로고
    • Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis
    • Fries JF, Singh G, Lenert L, Furst DE. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 1990;33:1611-9.
    • (1990) Arthritis Rheum , vol.33 , pp. 1611-1619
    • Fries, J.F.1    Singh, G.2    Lenert, L.3    Furst, D.E.4
  • 13
    • 0025269503 scopus 로고
    • Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis
    • Stewart CF, Fleming RA, Arkin CR, Evans WE. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 1990;47:540-6.
    • (1990) Clin Pharmacol Ther , vol.47 , pp. 540-546
    • Stewart, C.F.1    Fleming, R.A.2    Arkin, C.R.3    Evans, W.E.4
  • 14
    • 0025125626 scopus 로고
    • Lack of significant interaction between low-dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis
    • Skeith KJ, Russell AS, Jamali F, Coates J, Friedman H. Lack of significant interaction between low-dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. J Rheumatol 1990; 17:1008-10.
    • (1990) J Rheumatol , vol.17 , pp. 1008-1010
    • Skeith, K.J.1    Russell, A.S.2    Jamali, F.3    Coates, J.4    Friedman, H.5
  • 15
    • 0025160135 scopus 로고
    • Effect of aspirin and sulindac on methotrexate clearance
    • Furst DE, Herman RA, Koehnke R, et al. Effect of aspirin and sulindac on methotrexate clearance. J Pharmacol Sci 1990;79:782-6.
    • (1990) J Pharmacol Sci , vol.79 , pp. 782-786
    • Furst, D.E.1    Herman, R.A.2    Koehnke, R.3
  • 17
    • 0028297915 scopus 로고
    • Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis
    • Anaya J, Fabre D, Bressolle F. et al. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis. J Rheumatol 1994;21:203-8.
    • (1994) J Rheumatol , vol.21 , pp. 203-208
    • Anaya, J.1    Fabre, D.2    Bressolle, F.3
  • 18
    • 0029053714 scopus 로고
    • Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients
    • Combe B, Edno L, Lafforgue P, et al. Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients. Br J Rheumatol 1995;34:421-8.
    • (1995) Br J Rheumatol , vol.34 , pp. 421-428
    • Combe, B.1    Edno, L.2    Lafforgue, P.3
  • 19
    • 0028792273 scopus 로고
    • The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: Impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg
    • Kremer JM, Hamilton RA. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg. J Rheumatol 1995;22:2072-7.
    • (1995) J Rheumatol , vol.22 , pp. 2072-2077
    • Kremer, J.M.1    Hamilton, R.A.2
  • 20
    • 1842299887 scopus 로고    scopus 로고
    • Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis
    • Hubner G, Sander O, Degner FL, Turck D, Rau R. Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis. J Rheumatol 1997;24:845-51.
    • (1997) J Rheumatol , vol.24 , pp. 845-851
    • Hubner, G.1    Sander, O.2    Degner, F.L.3    Turck, D.4    Rau, R.5
  • 21
    • 0027986841 scopus 로고
    • Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs
    • Laneuville O, Breuer DK, DeWitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994;271:927-34.
    • (1994) J Pharmacol Exp Ther , vol.271 , pp. 927-934
    • Laneuville, O.1    Breuer, D.K.2    Dewitt, D.L.3    Hla, T.4    Funk, C.D.5    Smith, W.L.6
  • 22
    • 0030017042 scopus 로고    scopus 로고
    • Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts
    • Kargman S, Charleson S, Cartwright M, et al. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 1996;111:445-54.
    • (1996) Gastroenterology , vol.111 , pp. 445-454
    • Kargman, S.1    Charleson, S.2    Cartwright, M.3
  • 23
    • 0025754779 scopus 로고
    • Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
    • Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6.
    • (1991) Proc Natl Acad Sci USA , vol.88 , pp. 2692-2696
    • Xie, W.1    Chipman, J.G.2    Robertson, D.L.3    Erikson, R.L.4    Simmons, D.L.5
  • 24
    • 0025871150 scopus 로고
    • TIS10, a phorbol ester tumor promoter-inducible mRNA from swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
    • Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-72.
    • (1991) J Biol Chem , vol.266 , pp. 12866-12872
    • Kujubu, D.A.1    Fletcher, B.S.2    Varnum, B.C.3    Lim, R.W.4    Herschman, H.R.5
  • 25
    • 0031679914 scopus 로고    scopus 로고
    • Interspecies differences in renal localization of cyclooxygenase isoforms: Implications in nonsteroidal antiinflammatory drug-related nephrotoxicity
    • Khan KNM, Venturini CM, Bunch RT, et al. Interspecies differences in renal localization of cyclooxygenase isoforms: Implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol Pathol 1998;26:612-20.
    • (1998) Toxicol Pathol , vol.26 , pp. 612-620
    • Khan, K.N.M.1    Venturini, C.M.2    Bunch, R.T.3
  • 26
    • 13444266910 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cylooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-l-yl] benzenesulfonamide (SC-58635, celecoxib)
    • Penning TD, Talley JJ, Bertenshaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cylooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-l-yl] benzenesulfonamide (SC-58635, celecoxib). J Med Chem 1997;40:1347-65.
    • (1997) J Med Chem , vol.40 , pp. 1347-1365
    • Penning, T.D.1    Talley, J.J.2    Bertenshaw, S.R.3
  • 27
    • 0031680203 scopus 로고    scopus 로고
    • Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
    • Simon LS, Lanza FL, Lipsky PE, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum 1998;41:1591-602.
    • (1998) Arthritis Rheum , vol.41 , pp. 1591-1602
    • Simon, L.S.1    Lanza, F.L.2    Lipsky, P.E.3
  • 28
    • 0030787861 scopus 로고    scopus 로고
    • Outcome of specific COX-2 inhibition in rheumatoid arthritis
    • Lipsky PE. Isakson PC. Outcome of specific COX-2 inhibition in rheumatoid arthritis. J Rheumatol 1997;24 Suppl 49:9-14.
    • (1997) J Rheumatol , vol.24 , Issue.SUPPL. 49 , pp. 9-14
    • Lipsky, P.E.1    Isakson, P.C.2
  • 29
    • 0023853643 scopus 로고
    • Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis
    • Weinblatt ME, Trentham DE, Fraser PA, et al. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:167-75.
    • (1988) Arthritis Rheum , vol.31 , pp. 167-175
    • Weinblatt, M.E.1    Trentham, D.E.2    Fraser, P.A.3
  • 30
    • 0024400067 scopus 로고
    • Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment
    • Alarcon GS, Tracy IC, Blackburn WD Jr. Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 1989;32:671-6.
    • (1989) Arthritis Rheum , vol.32 , pp. 671-676
    • Alarcon, G.S.1    Tracy, I.C.2    Blackburn W.D., Jr.3
  • 31
    • 84960561529 scopus 로고
    • Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis
    • Furst DE. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis. Br J Rheumatol 1995;34 Suppl 2:20-5.
    • (1995) Br J Rheumatol , vol.34 , Issue.SUPPL. 2 , pp. 20-25
    • Furst, D.E.1
  • 32
    • 0033524421 scopus 로고    scopus 로고
    • Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
    • McAdam BF, Catella-Lawson F, Mardini IA, et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999;96:272-7.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 272-277
    • McAdam, B.F.1    Catella-Lawson, F.2    Mardini, I.A.3
  • 33
    • 0021359905 scopus 로고
    • Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption
    • Hendel J. Nyfors A. Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption. Eur J Clin Pharmacol 1984;26:121-4.
    • (1984) Eur J Clin Pharmacol , vol.26 , pp. 121-124
    • Hendel, J.1    Nyfors, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.